Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa

被引:117
作者
Lepper, PM
Grusa, E
Reichl, H
Högel, J
Trautmann, M
机构
[1] Ulm Univ Hosp, Dept Med Microbiol & Hyg, Sect Hosp Hyg, Ulm, Germany
[2] Univ Ulm, Inst Biomet & Med Documetat, D-89069 Ulm, Germany
[3] Klinikum Memmingen, Microbiol Lab, Memmingen, Germany
关键词
D O I
10.1128/AAC.46.9.2920-2925.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It is generally assumed that the antibiotic prescription policy of a hospital has a significant impact on bacterial resistance rates; however, few studies are available to support this concept with valid statistical data. During a 3-year period from 1997 to 2000, we monitored the consumption of P-lactam and other antibiotics,with known activity against Pseudomonas aeruginosa in a 600-bed community hospital. Monthly isolations of P. aeruginosa were assessed, and resistance rates were recorded. Partial correlation coefficients between consumption and resistance rates were determined, taking into account possible associations with other variables such as seasonal effects and transfers from other hospitals. A total of 30 +/- 7 novel P. aeruginosa strains per month were isolated without epidemic clustering. Prescriptions of imipenem varied significantly during the study period, while prescriptions of other antipseudomonal agents were stable, with the exception of an increase in piperacillin-tazobactam prescriptions. Rates of resistance of P. aeruginosa to the antimicrobial agents used showed a time course similar to figures for imipenem consumption. Monthly rates of resistance to imipenem (partial correlation coefficient [cc], 0.63), piperacillin-tazobactam (cc, 0.57), and ceftazidime (cc, 0.56) were significantly associated with imipenem prescription rates in the same or the preceding month, while consumption of ceftazidime or piperacillin-tazobactam had no apparent association with resistance. Among the variables investigated, imipenem consumption was identified as the major factor associated with both carbapenem and P-lactam resistance in endemic P. aeruginosa. Periods of extensive imipenem use were associated with significant increases in resistance. Our data support the concept that a written antibiotic policy which balances the use of various antibiotic classes may help to avoid disturbances of a hospital's microbial sensitivity patterns.
引用
收藏
页码:2920 / 2925
页数:6
相关论文
共 27 条
  • [1] Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
    Carmeli, Y
    Troillet, N
    Karchmer, AW
    Samore, MH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) : 1127 - 1132
  • [2] Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents
    Carmeli, Y
    Troillet, N
    Eliopoulos, GM
    Samore, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1379 - 1382
  • [3] Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer -: Retrospective analysis of 245 episodes
    Chatzinikolaou, I
    Abi-Said, D
    Bodey, GP
    Rolston, KVI
    Tarrand, JJ
    Samonis, G
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) : 501 - 509
  • [4] PROSPECTIVE RANDOMIZED COMPARISON OF IMIPENEM MONOTHERAPY WITH IMIPENEM PLUS NETILMICIN FOR TREATMENT OF SEVERE INFECTIONS IN NONNEUTROPENIC PATIENTS
    COMETTA, A
    BAUMGARTNER, JD
    LEW, D
    ZIMMERLI, W
    PITTET, D
    CHOPART, P
    SCHAAD, U
    HERTER, C
    EGGIMANN, P
    HUBER, O
    RICOU, B
    SUTER, P
    AUCKENTHALER, R
    CHIOLERO, R
    BILLE, J
    SCHEIDEGGER, C
    FREI, R
    GLAUSER, MP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) : 1309 - 1313
  • [5] *DTSC I NORM, 2000, METH ANT SUSC TEST B, P1
  • [6] Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit
    Foca, M
    Jakob, K
    Whittier, S
    Della Latta, P
    Factor, S
    Rubenstein, D
    Saiman, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (10) : 695 - 700
  • [7] EMERGENCE OF VANCOMYCIN-RESISTANT ENTEROCOCCI IN NEW-YORK-CITY
    FRIEDEN, TR
    MUNSIFF, SS
    LOW, DE
    WILLEY, BM
    WILLIAMS, G
    FAUR, Y
    EISNER, W
    WARREN, S
    KREISWIRTH, B
    [J]. LANCET, 1993, 342 (8863) : 76 - 79
  • [8] Rotation and restricted use of antibiotics in a medical intensive cave unit - Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria
    Gruson, D
    Hilbert, G
    Vargas, F
    Valentino, R
    Bebear, C
    Allery, A
    Bebear, C
    Gbikpi-Benissan, G
    Cardinaud, JP
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) : 837 - 843
  • [9] Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa
    Harris, A
    Torres-Viera, C
    Venkataraman, L
    DeGirolami, P
    Samore, M
    Carmeli, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) : 1128 - 1133
  • [10] Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients
    Harris, AD
    Smith, D
    Johnson, JA
    Bradham, DD
    Roghmann, MC
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) : 340 - 345